User:Mr. Ibrahem/Atogepant

Atogepant, sold under the brand name Qulipta, is a medication used to prevent migraines. It is taken by mouth once per day. Its use dose not appear to result in medication overuse headaches.

Commons side effects include nausea, constipation, and tiredness. Use in pregnancy may harm the baby. It should not be taken by people with significant liver problems. It is a calcitonin gene-related peptide receptor (CGRPR) antagonist, specifically a gepant.

Atogepant was approved for medical use in the United States in 2021. As of 2022 it is not approved in either Europe or the United Kingdom. In the United States it costs about 1,000 USD per month.